Legal & governance

Editorial and reference policy

We distinguish company information, planned portfolio particulars and scientific references so readers can understand what each source establishes and where its limits lie.

This notice applies to the Luang Pharma corporate website. It is published for information and is not legal or medical advice.

Different types of information

Corporate information describes Luang Pharma and its facility project. Portfolio information identifies planned substances, dosage forms, strengths and presentations; a listing does not establish registration, production or release. Scientific reference notes provide general context using identified external sources.

These are separate forms of information. A scientific publication does not verify the company’s equipment, capacity, approvals or supply capability. A project planning document does not establish a medicine’s clinical efficacy. The development status shown on the website applies independently of the clinical literature associated with an active substance.

Source selection

Our reference standard gives priority to the relevant competent authority for regulatory decisions and approved product information. Public-health authorities and international organisations provide broader health context. Primary research, evidence reviews and professional guidelines address scientific questions, subject to the scope and limitations of each source.

Links identify the publisher and subject. A specific label or paper concerns the product, study population and circumstances stated in that document. Links to databases or search resources help readers locate further material; they are not evidence that every result supports the page. A source’s inclusion is not an endorsement of Luang Pharma by its publisher.

Medicine-specific context

A reference for one salt, formulation, route or release type does not automatically apply to another. The same active substance can have different authorised indications, strengths and restrictions in different countries. Current, locally approved product information remains the relevant product-specific reference.

Clinical findings for a reference medicine do not establish equivalence, interchangeability, safety or benefit for a planned Luang Pharma product. Those conclusions require evidence for the precise product and claim. A pharmacological mechanism, early study or proposed indication is not an approved clinical benefit.

Balance, completeness and publication

The reference notes provide general scientific context and identify relevant limits. They are not complete prescribing monographs or recommendations for self-treatment. They do not confer an approved indication or establish the suitability of a planned product for an individual patient.

Expandable sections organise longer material for easier reading. Their content has the same status as the rest of the page. Development-status and medical-reference notices apply whether a section is open or closed. External links provide further context; they do not establish company approval, certification or a relationship with the cited institution.

Dates, authorship and review

The reference material in this revision was prepared with AI assistance and checked against the cited sources. No independent clinical reviewer is named for this revision. Source checking is not medical or regulatory sign-off, and the material does not replace professional clinical judgement.

A named author or reviewer is credited only for work they actually performed and authorised for attribution. A page’s update date identifies its website revision; it does not mean every linked source was issued or independently reviewed on that date.

Reference material can become outdated as evidence, regulatory decisions and company facts change. Corrections may include revised wording, a different source or removal of a statement. The published page and its references define the material available to readers; supporting internal working documents are not part of the public website.

Corrections and independence

Send a suspected error to the contact form with the page address, the disputed statement and a reliable supporting source if available. Clearly identify a medical safety concern so it can be routed appropriately. Please omit unnecessary patient information from a correction request.

Luang Pharma publishes the website as the company concerned and therefore has a commercial interest in its corporate presentation. Scientific links do not turn it into an independent medical service. There are no paid third-party advertisements or sponsored medicine recommendations within the public website. External organisations retain responsibility for their own material and do not endorse Luang Pharma by being cited.